RPS6KA3 and Coffin-Lowry syndrome: While the use of siRNAs, the overexpression of kinase dead Rsk mutants or cells from Rsk2-deficient mice or from patients with Coffin–Lowry syndrome have been helpful, the simultaneous expression of the Rsk1, 2 and 3 in most cell types has complicated the study of their cellular functions.